Cargando…

Osteonecrosis of the Jaw and Antiresorptive Agents in Benign and Malignant Diseases: A Critical Review Organized by the ECTS

CONTEXT: Antiresorptive therapy significantly reduces fracture risk in patients with benign bone disease and skeletal-related events (SREs) in patients with bone metastases (BM). Osteonecrosis of the jaw (ONJ) is a rare but severe condition manifested as necrotic bone lesion or lesions of the jaws....

Descripción completa

Detalles Bibliográficos
Autores principales:	Anastasilakis, Athanasios D, Pepe, Jessica, Napoli, Nicola, Palermo, Andrea, Magopoulos, Christos, Khan, Aliya A, Zillikens, M Carola, Body, Jean-Jacques
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Reports and Recommendations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9016445/ https://www.ncbi.nlm.nih.gov/pubmed/34922381 http://dx.doi.org/10.1210/clinem/dgab888

Ejemplares similares

Response to Letter to the Editor From Taguchi: “Osteonecrosis of the Jaw and Antiresorptive Agents in Benign and Malignant Diseases: A Critical Review Organized by the ECTS”
por: Anastasilakis, Athanasios D, et al.
Publicado: (2022)

Antiresorptive agent-related osteonecrosis of the jaw in osteoporosis patients from Asian countries
por: Taguchi, Akira, et al.
Publicado: (2017)

Treatment of osteonecrosis of the jaw related to bisphosphonates and other antiresorptive agents
por: Rodriguez-Lozano, Francisco-Javier, et al.
Publicado: (2016)

Symposium: Imaging modalities for drug-related osteonecrosis of the jaw (4), CT and MR imaging findings of antiresorptive agent-related osteonecrosis of the jaws/medication-related osteonecrosis of the jaw (secondary publication)()
por: Baba, Akira, et al.
Publicado: (2019)

Incidence and trend of antiresorptive agent-related osteonecrosis of the jaw from 2016 to 2020 in Kure, Japan
por: Kunihara, Takahiro, et al.
Publicado: (2023)

Review and Update of the Risk Factors and Prevention of Antiresorptive-Related Osteonecrosis of the Jaw
por: Kim, Ha Young
Publicado: (2021)

Effectiveness of surgery and hyperbaric oxygen for antiresorptive agent-related osteonecrosis of the jaw: A subgroup analysis by disease stage
por: Watanabe, Takuma, et al.
Publicado: (2021)

Relationship between Drug Holidays of Antiresorptive Agents and Surgical Outcomes in Cancer Patients with Medication-Related Osteonecrosis of the Jaw
por: Otsuru, Mitsunobu, et al.
Publicado: (2022)

Medication-Related Osteonecrosis of the Jaw in Patients Treated Concurrently with Antiresorptive and Antiangiogenic Agents: Systematic Review and Meta-Analysis
por: Srivastava, Akanksha, et al.
Publicado: (2021)

Relationship between drug holiday of the antiresorptive agents and surgical outcome of medication-related osteonecrosis of the jaw in osteoporosis patients
por: Morishita, Kota, et al.
Publicado: (2022)

Incidence of antiresorptive agent-related osteonecrosis of the jaw: A multicenter retrospective epidemiological study in Hyogo Prefecture, Japan
por: Nashi, Masanori, et al.
Publicado: (2023)

Osteonecrosis of the Jaw Associated with Antiangiogenics in Antiresorptive-Naïve Patient: A Comprehensive Review of the Literature
por: Pimolbutr, Kununya, et al.
Publicado: (2018)

Predictive Value of Neutrophil–Lymphocyte Ratio as a Marker in Antiresorptive Agent-Related Osteonecrosis of the Jaw: A Retrospective Analysis
por: Kurohara, Kazuto, et al.
Publicado: (2022)

Histopathological findings affect quantitative values of single photon emission computed tomography in patients with antiresorptive agent-related osteonecrosis of the jaws
por: Okui, Taro, et al.
Publicado: (2023)

The role of antiresorptive drugs and medication-related osteonecrosis of the jaw in nononcologic immunosuppressed patients: A systematic review
por: Sacco, Roberto, et al.
Publicado: (2021)

The Effect of Antiresorptive Drug Holidays on Medication-Related Osteonecrosis of the Jaw: A Systematic Review and Meta-Analysis
por: Aboalela, Ali A, et al.
Publicado: (2022)

Intraoral localized methotrexate‐associated lymphoproliferative disorders concurrent with antiresorptive agent‐related osteonecrosis of the jaw: A case report and literature review
por: Minabe, Masaki, et al.
Publicado: (2020)

Contribution of Antiangiogenic Agents to the Risk of Medication-related Osteonecrosis of the Jaw in Combination with Antiresorptive Agents: Preliminary Results in a Comparative Prospective Report of 59 Oncologic Cases
por: Yanni, Antoine, et al.
Publicado: (2022)

Standardisation of labial salivary gland histopathology in clinical trials in primary Sjögren's syndrome
por: Fisher, Benjamin A, et al.
Publicado: (2017)

Could the Combined Administration of Bone Antiresorptive Drug, Taxanes, and Corticosteroids Worsen Medication Related Osteonecrosis of the Jaws in Cancer Patients?
por: Oteri, Giacomo, et al.
Publicado: (2018)

The risk of osteonecrosis of the jaw and adverse outcomes in patients using antiresorptive drugs undergoing orthodontic treatment: A systematic review
por: Woolley, Julian, et al.
Publicado: (2021)

Comparative effectiveness of first-line tumour necrosis factor inhibitor versus non-tumour necrosis factor inhibitor biologics and targeted synthetic agents in patients with rheumatoid arthritis: results from a large US registry study
por: Pappas, Dimitrios A, et al.
Publicado: (2021)

Medical Management of Patients After Atypical Femur Fractures: a Systematic Review and Recommendations From the European Calcified Tissue Society
por: van de Laarschot, Denise M, et al.
Publicado: (2019)

Design and methods for a Scandinavian pharmacovigilance study of osteonecrosis of the jaw and serious infections among cancer patients treated with antiresorptive agents for the prevention of skeletal-related events
por: Acquavella, John, et al.
Publicado: (2016)

Ineffectiveness of Antiresorptive Agent Drug Holidays in Osteoporosis Patients for Treatment of Medication-Related Osteonecrosis of the Jaw: Consideration from Immunohistological Observation of Osteoclast Suppression and Treatment Outcomes
por: Omori, Keisuke, et al.
Publicado: (2022)

Medication-Related Osteonecrosis of the Jaw (MRONJ): Are Antiresorptive Drugs the Main Culprits or Only Accomplices? The Triggering Role of Vitamin D Deficiency
por: Dalle Carbonare, Luca, et al.
Publicado: (2021)

Genome-wide association study of osteonecrosis of the jaw in Danish patients receiving antiresorptive therapy for osteoporosis: A case-control study
por: Pedersen, Alma B., et al.
Publicado: (2022)

Medication‐related osteonecrosis of the jaw and successful implant treatment in a patient on high‐dose antiresorptive medication: A case report
por: Ottesen, Camilla, et al.
Publicado: (2022)

Medication-Related Osteonecrosis of the Jaws: Considerations on a New Antiresorptive Therapy (Denosumab) and Treatment Outcome after a 13-Year Experience
por: Favia, Gianfranco, et al.
Publicado: (2016)

Efficacy of a high-dose antiresorptive drug holiday to reduce the risk of medication-related osteonecrosis of the jaw (MRONJ): A systematic review
por: Ottesen, Camilla, et al.
Publicado: (2020)

Real-world study of antiresorptive-related osteonecrosis of jaw based on the US food and drug administration adverse event reporting system database
por: Peng, Jing, et al.
Publicado: (2022)

EULAR points to consider for the diagnosis and management of rheumatic immune-related adverse events due to cancer immunotherapy with checkpoint inhibitors
por: Kostine, Marie, et al.
Publicado: (2021)

Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force
por: Smolen, Josef S, et al.
Publicado: (2016)

Osteonecrosis of the Jaw
por: Lončar Brzak, Božana, et al.
Publicado: (2023)

Osteonecrosis of the Jaw among Patients Receiving Antiresorptive Medication: A 4-year Retrospective Study at a Tertiary Cancer Center, Kerala, India
por: Sankar, Pramod S, et al.
Publicado: (2018)

Risk profile for antiangiogenic agent-related osteonecrosis of the jaws
por: Caminha, Raquel D’Aquino Garcia, et al.
Publicado: (2019)

Concentration of Penicillin G in Jawbone Affected by Antiresorptive Agent-Related Osteonecrosis Following a Single Preoperative Dose
por: Poxleitner, Philipp, et al.
Publicado: (2020)

Heidelberg Consensus Recommendations on Trustmarks
Publicado: (2000)

Treatment recommendations for psoriatic arthritis
por: Ritchlin, C T, et al.
Publicado: (2009)

EULAR recommendations for terminology and research in individuals at risk of rheumatoid arthritis: report from the Study Group for Risk Factors for Rheumatoid Arthritis
por: Gerlag, Danielle M, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_hnblfbo1v6dq6shkvcrop7i5c0